XRTX

↓ PDF (Pro)

XORTX Therapeutics Inc. Common Shares

HealthcareBiotechnologyCanadaNASDAQ

$2.73

-1.44%today

MKT CAP

$4M

+30.0% · 1Y

Earnings History

+35.2%

+71.5%

Q3 '25

Q4 '25

Full Financials

Trailing P/E-

Forward P/E3.3x

EV/EBITDA-

Price/Sales-

Dividend Yield-

Revenue Growth YoY-

Earnings Growth YoY-

Revenue Growth QoQ-

5y Revenue CAGR-

5y Earnings CAGR-

Gross Margin-

Operating Margin-

Net Margin-

ROE-

Debt / Equity-

Free Cash Flow-

Insider Ownership10.3%

Institutional Ownership5.9%

Short % of Float2.93%

Days to Cover0.5d

1 Week-3.5%

1 Month-

3 Months-

6 Months-

YTD-

1 Year-

3 Years-

5 Years-

vs 50-day SMA-

vs 200-day SMA-

vs 52w High-

vs 52w Low-

Top Holders

Holder	Type	% Held	Value	Δ Shares	As of
DRW Securities, LLC	institution	2.78%	$0.00B	+100.00%	2025-12-31
Baader Bank Aktiengesellschaft	institution	0.27%	$0.00B	+100.00%	2025-12-31
Two Sigma Securities, LLC	institution	0.18%	$0.00B	+100.00%	2025-12-31
Royal Bank of Canada	institution	0.06%	$0.00B	+1036.11%	2025-12-31
Clearstead Advisors, LLC	institution	0.00%	$0.00B	+0.00%	2025-12-31

Peers

Compare side-by-side →

Ticker	Cap	Score	P/E	Fwd P/E	EV/EBITDA	ROE	Gross	D/E	Div
PTGX Protagonist Therapeutics Inc. Common Stock	$6.6B	5	-	-	-	-	-	-	0.00%
CELC Celcuity Inc. Common Stock	$6.7B	5	-	-	-	-	-	-	0.00%
ACLX Arcellx Inc. Common Stock	$6.7B	5	-	-	-	-	-	-	-
KYMR Kymera Therapeutics Inc. Common Stock	$7.0B	-	-	-	-	-27.1%	0%	5.23	0.00%
TECH Bio-Techne Corp Common Stock	$7.1B	36	72.7	24.4	-	-	-	-	63.00%
HALO Halozyme Therapeutics Inc. Common Stock	$7.9B	73	25.5	6.6	-	-	-	-	0.00%